Unknown

Dataset Information

0

Targeting Bcl-2 Proteins in Acute Myeloid Leukemia.

ABSTRACT: B cell lymphoma 2 (BCL-2) family proteins play an important role in intrinsic apoptosis. Overexpression of BCL-2 proteins in acute myeloid leukemia can circumvent resistance to apoptosis and chemotherapy. Considering this effect, the exploration of anti-apoptotic BCL-2 inhibitors is considered to have tremendous potential for the discovery of novel pharmacological modulators in cancer. This review outlines the impact of BCL-2 family proteins on intrinsic apoptosis and the development of acute myeloid leukemia (AML). Furthermore, we will also review the new combination therapy with venetoclax that overcomes resistance to venetoclax and discuss biomarkers of treatment response identified in early-phase clinical trials.

SUBMITTER: Wei Y 

PROVIDER: S-EPMC7674767 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Targeting Bcl-2 Proteins in Acute Myeloid Leukemia.

Wei Yunxiong Y   Cao Yaqing Y   Sun Rui R   Cheng Lin L   Xiong Xia X   Jin Xin X   He Xiaoyuan X   Lu Wenyi W   Zhao Mingfeng M  

Frontiers in oncology 20201105

B cell lymphoma 2 (BCL-2) family proteins play an important role in intrinsic apoptosis. Overexpression of BCL-2 proteins in acute myeloid leukemia can circumvent resistance to apoptosis and chemotherapy. Considering this effect, the exploration of anti-apoptotic BCL-2 inhibitors is considered to have tremendous potential for the discovery of novel pharmacological modulators in cancer. This review outlines the impact of BCL-2 family proteins on intrinsic apoptosis and the development of acute my  ...[more]

Similar Datasets

Unknown Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
| S-EPMC4608389 | biostudies-literature
Unknown RNA Targeting in Acute Myeloid Leukemia.
| S-EPMC7737216 | biostudies-literature
Unknown Targeting MTHFD2 in acute myeloid leukemia.
| S-EPMC4925018 | biostudies-literature
Unknown Molecular targeting in acute myeloid leukemia.
| S-EPMC5576374 | biostudies-literature
Unknown Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia.
| S-EPMC4901329 | biostudies-literature
Unknown 225Ac-labeled CD33-targeting antibody reverses resistance to Bcl-2 inhibitor venetoclax in acute myeloid leukemia models.
| S-EPMC7897952 | biostudies-literature
Unknown Targeting FLT3 Mutations in Acute Myeloid Leukemia.
| S-EPMC5789277 | biostudies-literature
Unknown Potential targeting of FLT3 acute myeloid leukemia.
| S-EPMC7927884 | biostudies-literature
Unknown Targeting Chromatin Regulation in Acute Myeloid Leukemia.
| S-EPMC8171376 | biostudies-literature
Unknown Targeting CD33 for acute myeloid leukemia therapy.
| S-EPMC8722076 | biostudies-literature